Evidence map›Paper›PMID 38547574›Full record

ArticleAsian journal of psychiatry2024

Beyond conventional: Feasibility of accelerated tACS in clozapine-resistant schizophrenia - A case report.

Harsh Pathak, Kiran Bagali, Swarna Buddha Nayok, Sonika Nichenametla, Vyoma Shah, Mitali Shroff, Vanteemar S Sreeraj, Ganesan Venkatasubramanian

Open access · greenAbstract readLetterCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Harsh PathakDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Kiran BagaliDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Swarna Buddha NayokDepartment of Clinical Neurosciences, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Sonika NichenametlaDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Vyoma ShahDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Mitali ShroffDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Vanteemar S SreerajDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India. Electronic address: vs8sreeraj@yahoo.com.
Ganesan VenkatasubramanianDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India; Department of Clinical Neurosciences, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
National Institute of Mental Health and Neurosciences · IN

Funding

DBT-Wellcome Trust India Alliance IA/CRC/19/1/610005Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsClozapineAdultElectroconvulsive TherapyFeasibility StudiesFemaleHumansSchizophreniaSchizophrenia, Treatment-ResistantTreatment OutcomeAntipsychotic AgentsClozapine

Identifiers

PMID38547574
PMCPMC7615994
OpenAlexW4393194311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.